Present concepts in management of atrial fibrillation: From drug therapy to ablation.
暂无分享,去创建一个
[1] S. Connolly,et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.
[2] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[3] Maurice Buchbinder,et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.
[4] Salim Yusuf,et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[5] Frank Bogun,et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. , 2009, Journal of the American College of Cardiology.
[6] J. Healey,et al. A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation , 2009, Journal of cardiovascular electrophysiology.
[7] C. Tondo,et al. Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy , 2009, Journal of cardiovascular electrophysiology.
[8] F. Sacher,et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study , 2008, Circulation.
[9] Atul Verma,et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. , 2008, Heart rhythm.
[10] Jeremy N Ruskin,et al. Initial experience with the Mesh catheter for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. , 2008, Heart rhythm.
[11] David O. Martin,et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.
[12] Michael A. E. Schneider,et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. , 2008, Journal of the American College of Cardiology.
[13] A. Camm,et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .
[14] J. McMurray,et al. Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.
[15] F. Romeo,et al. Transthoracic Versus Transesophageal Cardioversion of Atrial Fibrillation under Light Sedation: A Prospective Randomized Trial , 2007, Pacing and clinical electrophysiology : PACE.
[16] R. Mantovan,et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. , 2007, Heart rhythm.
[17] E. Aliot,et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.
[18] S. Yusuf,et al. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study. , 2007, American heart journal.
[19] M. Santini,et al. Outpatient oesophageal–precordial electrical cardioversion of atrial fibrillation: an effective and safe technique to restore sinus rhythm , 2007, Journal of cardiovascular medicine.
[20] C. Armon. Amiodarone for atrial fibrillation. , 2007, The New England journal of medicine.
[21] Frank Bogun,et al. Radiofrequency Catheter Ablation of Chronic Atrial Fibrillation Guided by Complex Electrograms , 2007, Circulation.
[22] G. Hindricks,et al. Venice Chart International Consensus Document on Atrial Fibrillation Ablation , 2007, Journal of cardiovascular electrophysiology.
[23] J. Ruskin,et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.
[24] David O. Martin,et al. Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. , 2007, Journal of the American College of Cardiology.
[25] A. Goette,et al. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling). , 2007, Current opinion in pharmacology.
[26] Tom Wong,et al. Initial Experience Using a Forward Directed, High‐Intensity Focused Ultrasound Balloon Catheter for Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.
[27] V. Santinelli,et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. , 2006, Journal of the American College of Cardiology.
[28] C. Tondo,et al. Pulmonary Vein Vestibule Ablation for the Control of Atrial Fibrillation in Patients with Impaired Left Ventricular Function , 2006, Pacing and clinical electrophysiology : PACE.
[29] Frank Bogun,et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.
[30] Susan B. Johnson,et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. , 2005, Journal of the American College of Cardiology.
[31] G. Lip,et al. Antithrombotic treatment in atrial fibrillation , 2005, Postgraduate Medical Journal.
[32] P. Teirstein,et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.
[33] M. Santini,et al. Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique , 2005, Expert review of cardiovascular therapy.
[34] Mandeep Bhargava,et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.
[35] D. Reda,et al. Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.
[36] Elia Biganzoli,et al. Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.
[37] Douglas Packer,et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation.
[38] Prashanthan Sanders,et al. Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.
[39] K. Nademanee,et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. , 2004, Journal of the American College of Cardiology.
[40] Brian Olshansky,et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation. , 2004, Journal of the American College of Cardiology.
[41] M. Santini,et al. Oesophageal electrical cardioversion of atrial fibrillation. , 2004, Minerva Cardioangiologica : a Journal on Cardiovascular Pathophysiology, Clinical Medicine and Therapy.
[42] M. Domanski,et al. Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.
[43] David O. Martin,et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. , 2004, Journal of the American College of Cardiology.
[44] P. McCarthy,et al. Advances in surgical treatment of atrial fibrillation. , 2004, Stroke.
[45] L. Tamariz,et al. Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.
[46] Otto Kamp,et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. , 2004, Journal of the American College of Cardiology.
[47] J. Boineau,et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. , 2003, The Journal of thoracic and cardiovascular surgery.
[48] Affirm Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. , 2003, Journal of the American College of Cardiology.
[49] Hirotsugu Yamada,et al. Phased-Array Intracardiac Echocardiography Monitoring During Pulmonary Vein Isolation in Patients With Atrial Fibrillation: Impact on Outcome and Complications , 2003, Circulation.
[50] M. Bulsara,et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.
[51] U. Tebbe,et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.
[52] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[53] Simon Stewart,et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.
[54] R. Kerber,et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. , 2002, Journal of the American College of Cardiology.
[55] L. Goldman,et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.
[56] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[57] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[58] C. Kang,et al. Modifications of the Cox-Maze III procedure. , 2000, The Annals of thoracic surgery.
[59] P. Tchou,et al. First Human Experience With Pulmonary Vein Isolation Using a Through-the-Balloon Circumferential Ultrasound Ablation System for Recurrent Atrial Fibrillation , 2000, Circulation.
[60] A. Aggarwal. Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.
[61] S. Connolly,et al. Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .
[62] P. Tchou,et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.
[63] O. Benavente,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.
[64] C. Pandozi,et al. Single Shock Endocavitary Low Energy Intracardiac Cardioversion of Chronic Atrial Fibrillation , 1999, Journal of Interventional Cardiac Electrophysiology.
[65] Bramahn . Singh,et al. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.
[66] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[67] L. Thuesen,et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.
[68] J. Boineau,et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. , 1995, The Journal of thoracic and cardiovascular surgery.
[69] W. Stevenson,et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. , 1995, The American journal of cardiology.
[70] A Laupacis,et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.
[71] Y. Kawashima,et al. Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease. , 1994, The Journal of thoracic and cardiovascular surgery.
[72] P B Corr,et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.
[73] W. Kannel,et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. , 1982, The New England journal of medicine.
[74] B. Gersh,et al. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[75] E. Benjamin,et al. Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.
[76] J. Camm,et al. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation , 2008, Nature Clinical Practice Cardiovascular Medicine.
[77] Antonio De Simone,et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.
[78] J. Halperin,et al. Obliteration of the left atrial appendage for prevention of thromboembolism. , 2003, Journal of the American College of Cardiology.
[79] S Nattel,et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. , 2000, The New England journal of medicine.